Orthofix International reported $137.23M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
Accuray USD 170.24M 4.52M Sep/2024
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 71.78M 1.6M Mar/2026
Dexcom USD 1.24B 900K Mar/2026
EDAP TMS EUR 27.79M 20.24M Mar/2026
Globus Medical USD 115.22M 3.43M Mar/2026
Inogen USD 0 0 Jun/2022
Insulet USD 948.4M 300K Jun/2026
Integra LifeSciences USD 2.04B 6.27M Mar/2026
J&J USD 54.99B 7.05B Mar/2026
Medtronic USD 28.07B 1.03B Dec/2025
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Orthofix International USD 137.23M 338K Sep/2024
Plus Therapeutics USD 3.98M 372K Dec/2023
STAAR Surgical USD 37.29M 1.06M Mar/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 132.16M Jun/2026
Teleflex USD 2.69B 39.95M Mar/2026
Veracyte USD 39.33M 321K Mar/2026
Zimmer Biomet Holdings USD 7.48B 8M Jun/2026